CORT  valuation analysis

Basics
Name: Corcept Therapeutics Incorporated
Description: Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $2.66B (581st)
Sales(TTM): $340.06M (754th)
Earnings(TTM): $99.41M (491st)

Value
FFER: 1.22 (why)
Actual price: $22.82
FFEThis is Corcept Therapeutics Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $17.65
Quantile: CORT is expensive given its fundamentals.
Prices as of EOD 2021-06-16
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Corcept Therapeutics Incorporated
"Biotechnology" industry
Sales / MarketCap
Corcept Therapeutics Incorporated
"Biotechnology" industry
Book / MarketCap
Corcept Therapeutics Incorporated
"Biotechnology" industry
Equity / Assets
Corcept Therapeutics Incorporated
"Biotechnology" industry